{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:40:16Z","timestamp":1790941216968,"version":"4.1.0"},"reference-count":60,"publisher":"American Diabetes Association","issue":"2","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,2,1]]},"abstract":"<jats:p>Transgenic mice expressing the amyloidogenic human islet amyloid polypeptide (hIAPP) in their islet \u03b2-cells are a model of islet amyloid formation as it occurs in type 2 diabetes. Our hIAPP transgenic mice developed islet amyloid when fed a breeder chow but not regular chow. Because the breeder chow contained increased amounts of fat, we hypothesized that increased dietary fat enhances islet amyloid formation. To test this hypothesis, we fed male hIAPP transgenic and nontransgenic control mice diets containing 15% (low fat), 30% (medium fat), or 45% (high fat) of calories derived from fat for 12 months, and we measured islet amyloid, islet endocrine cell composition, and \u03b2-cell function. Increased dietary fat in hIAPP transgenic mice was associated with a dose-dependent increase in both the prevalence (percentage of islets containing amyloid deposits; 34 \u00b1 8, 45 \u00b1 8, and 58 \u00b1 10%, P &amp;lt; 0.05) and severity (percentage of islet area occupied by amyloid; 0.8 \u00b1 0.5, 1.0 \u00b1 0.5, and 4.6 \u00b1 2.5%, P = 0.05) of islet amyloid. In addition, in these hIAPP transgenic mice, there was a dose-dependent decrease in the proportion of islet area comprising \u03b2-cells, with no significant change in islet size. In contrast, nontransgenic mice adapted to diet-induced obesity by increasing their islet size more than twofold. Increased dietary fat was associated with impaired insulin secretion in hIAPP transgenic (P = 0.05) but not nontransgenic mice. In summary, dietary fat enhances both the prevalence and severity of islet amyloid and leads to \u03b2-cell loss and impaired insulin secretion. Because both morphologic and functional defects are present in hIAPP transgenic mice, this would suggest that the effect of dietary fat to enhance islet amyloid formation might play a role in the pathogenesis of the islet lesion of type 2 diabetes in humans.<\/jats:p>","DOI":"10.2337\/diabetes.52.2.372","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"372-379","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":100,"title":["Increased Dietary Fat Promotes Islet Amyloid Formation and \u03b2-Cell Secretory Dysfunction in a Transgenic Mouse Model of Islet Amyloid"],"prefix":"10.2337","volume":"52","author":[{"given":"Rebecca L.","family":"Hull","sequence":"first","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofianos","family":"Andrikopoulos","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Bruce","family":"Verchere","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Vidal","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cnop","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Prigeon","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven E.","family":"Kahn","sequence":"additional","affiliation":[{"name":"From the Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031217240693700_R1","doi-asserted-by":"crossref","unstructured":"Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes\u200837:1595\u20131607,1988","DOI":"10.2337\/diabetes.37.12.1595"},{"key":"2022031217240693700_R2","doi-asserted-by":"crossref","unstructured":"Pi-Sunyer FX: Medical hazards of obesity. Ann Intern Med\u2008119:655\u2013660,1993","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006"},{"key":"2022031217240693700_R3","doi-asserted-by":"crossref","unstructured":"Marshall JA, Hoag S, Shetterly S, Hamman RF: Dietary fat predicts conversion from impaired glucose tolerance to NIDDM: the San Luis Valley Diabetes Study. Diabetes Care\u200817:50\u201356,1994","DOI":"10.2337\/diacare.17.1.50"},{"key":"2022031217240693700_R4","doi-asserted-by":"crossref","unstructured":"Storlien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW: Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol\u2008251:E576\u2013E583,1986","DOI":"10.1152\/ajpendo.1986.251.5.E576"},{"key":"2022031217240693700_R5","doi-asserted-by":"crossref","unstructured":"Rocchini AP, Marker P, Cervenka T: Time course of insulin resistance associated with feeding dogs a high-fat diet. Am J Physiol\u2008272:E147\u2013E154,1997","DOI":"10.1152\/ajpendo.1997.272.1.E147"},{"key":"2022031217240693700_R6","doi-asserted-by":"crossref","unstructured":"Westermark P: Quantitative studies on amyloid in the islets of Langerhans. Ups J Med Sci\u200877:91\u201394,1972","DOI":"10.1517\/03009734000000014"},{"key":"2022031217240693700_R7","doi-asserted-by":"crossref","unstructured":"Clark A, Saad MF, Nezzer T, Uren C, Knowler WC, Bennett PH, Turner RC: Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians. Diabetologia\u200833:285\u2013289,1990","DOI":"10.1007\/BF00403322"},{"key":"2022031217240693700_R8","doi-asserted-by":"crossref","unstructured":"Westermark P: Amyloid and polypeptide hormones: what is their interrelationship? (Review) Amyloid-Int J Exp Clin Invest\u20081:47\u201360,1994","DOI":"10.3109\/13506129409148624"},{"key":"2022031217240693700_R9","doi-asserted-by":"crossref","unstructured":"Howard CF Jr: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia\u200829:301\u2013306,1986","DOI":"10.1007\/BF00452067"},{"key":"2022031217240693700_R10","doi-asserted-by":"crossref","unstructured":"Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC: Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide. Diabetes\u200847:743\u2013750,1998","DOI":"10.2337\/diabetes.47.5.743"},{"key":"2022031217240693700_R11","doi-asserted-by":"crossref","unstructured":"Hoppener JWM, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JHH, Vroom TM, Ahren B, Lips CJM: Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a mouse model. Diabetologia\u200842:427\u2013434,1999","DOI":"10.1007\/s001250051175"},{"key":"2022031217240693700_R12","doi-asserted-by":"crossref","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O\u2019Brien TD, Johnson KH: Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A\u200884:3881\u20133885,1987","DOI":"10.1073\/pnas.84.11.3881"},{"key":"2022031217240693700_R13","doi-asserted-by":"crossref","unstructured":"Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KBM: Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A\u200884:8628\u20138632,1987","DOI":"10.1073\/pnas.84.23.8628"},{"key":"2022031217240693700_R14","doi-asserted-by":"crossref","unstructured":"Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C: Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci U S A\u200887:5036\u20135040,1990","DOI":"10.1073\/pnas.87.13.5036"},{"key":"2022031217240693700_R15","doi-asserted-by":"crossref","unstructured":"Fox N, Schrementi J, Nishi M, Ohagi S, Chan SJ, Heisserman JA, Westermark GT, Leckstrom A, Westermark P, Steiner DF: Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes-mellitus (NIDDM). FEBS Lett\u2008323:40\u201344,1993","DOI":"10.1016\/0014-5793(93)81444-5"},{"key":"2022031217240693700_R16","doi-asserted-by":"crossref","unstructured":"Hoppener JWM, Verbeek JS, Dekoning EJP, Oosterwijk C, Vanhulst KL, Visservernooy HJ, Hofhuis FMA, Vangaalen S, Berends MJH, Hackeng WHL, Jansz HS, Morris JF, Clark A, Capel PJA, Lips CJM: Chronic overproduction of islet amyloid polypeptide (amylin) in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycemia or hyperinsulinemia. Diabetologia\u200836:1258\u20131265,1993","DOI":"10.1007\/BF00400803"},{"key":"2022031217240693700_R17","doi-asserted-by":"crossref","unstructured":"D\u2019Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW: Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse. Diabetes\u200843:1457\u20131461,1994","DOI":"10.2337\/diabetes.43.12.1457"},{"key":"2022031217240693700_R18","doi-asserted-by":"crossref","unstructured":"Yagui K, Yamaguchi T, Kanatsuka A, Shimada F, Huang CI, Tokuyama Y, Ohsawa H, Yamamura KI, Miyazaki JI, Mikata A, Yoshida S, Makino H: Formation of islet amyloid fibrils in beta-secretory granules of transgenic mice expressing human islet amyloid polypeptide (amylin). Eur J Endocrinol\u2008132:487\u2013496,1995","DOI":"10.1530\/eje.0.1320487"},{"key":"2022031217240693700_R19","doi-asserted-by":"crossref","unstructured":"Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A\u200893:7283\u20137288,1996","DOI":"10.1073\/pnas.93.14.7283"},{"key":"2022031217240693700_R20","doi-asserted-by":"crossref","unstructured":"Verchere CB, D\u2019Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A\u200893:3492\u20133496,1996","DOI":"10.1073\/pnas.93.8.3492"},{"key":"2022031217240693700_R21","doi-asserted-by":"crossref","unstructured":"Andrikopoulos S, Verchere CB, Terauchi Y, Kadowaki T, Kahn SE: \u03b2-Cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes. Diabetes\u200849:2056\u20132062.,2000","DOI":"10.2337\/diabetes.49.12.2056"},{"key":"2022031217240693700_R22","doi-asserted-by":"crossref","unstructured":"Morgan DR, Lazarow A: Immunoassay of insulin: two antibody system: Plasma insulin levels of normal, subdiabetic, and diabetic rats. Diabetes\u200812:115\u2013126,1963","DOI":"10.2337\/diab.12.2.115"},{"key":"2022031217240693700_R23","doi-asserted-by":"crossref","unstructured":"Percy AJ, Trainor DA, Rittenhouse J, Phelps J, Koda JE: Development of sensitive immunoassays to detect amylin and amylin-like peptides in unextracted plasma. Clin Chem\u200842:576\u2013585,1996","DOI":"10.1093\/clinchem\/42.4.576"},{"key":"2022031217240693700_R24","doi-asserted-by":"crossref","unstructured":"Wang F, Hull RL, Vidal J, Cnop M, Kahn SE: Islet amyloid develops diffusely throughout the pancreas before becoming severe and replacing endocrine cells. Diabetes\u200850:2514\u20132520,2001","DOI":"10.2337\/diabetes.50.11.2514"},{"key":"2022031217240693700_R25","doi-asserted-by":"crossref","unstructured":"Jonchkeere AR: A distribution-free $k$-sample test against ordered alternatives. Biometrika\u200841:133\u2013145,1954","DOI":"10.1093\/biomet\/41.1-2.133"},{"key":"2022031217240693700_R26","doi-asserted-by":"crossref","unstructured":"Kahn SE, Andrikopoulos S, Verchere CB, Wang F, Hull RL, Vidal J: Oophorectomy promotes islet amyloid formation in a transgenic mouse model of type II diabetes. Diabetologia\u200843:1309\u20131312,2000","DOI":"10.1007\/s001250051527"},{"key":"2022031217240693700_R27","doi-asserted-by":"crossref","unstructured":"Lee SK, Opara EC, Surwit RS, Feinglos MN, Akwari OE: Defective glucose-stimulated insulin release from perifused islets of C57BL\/6J mice. Pancreas\u200811:206\u2013211,1995","DOI":"10.1097\/00006676-199508000-00016"},{"key":"2022031217240693700_R28","doi-asserted-by":"crossref","unstructured":"Ludwig DS, Tritos NA, Mastaitis JW, Kulkarni R, Kokkotou E, Elmquist J, Lowell B, Flier JS, Maratos-Flier E: Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest\u2008107:379\u2013386.,2001","DOI":"10.1172\/JCI10660"},{"key":"2022031217240693700_R29","doi-asserted-by":"crossref","unstructured":"Westermark GT, Leckstrom A, Ma Z, Westermark P: Increased release of IAPP in response to long-term high fat intake in mice. Horm Metab Res\u200830:256\u2013258,1998","DOI":"10.1055\/s-2007-978878"},{"key":"2022031217240693700_R30","doi-asserted-by":"crossref","unstructured":"Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res\u20084:110\u2013125,1985","DOI":"10.1159\/000156969"},{"key":"2022031217240693700_R31","doi-asserted-by":"crossref","unstructured":"Gapp DA, Leiter EH, Coleman DL, Schwizer RW: Temporal changes in pancreatic islet composition in C57BL\/6J-db\/db (diabetes) mice. Diabetologia\u200825:439\u2013443,1983","DOI":"10.1007\/BF00282525"},{"key":"2022031217240693700_R32","doi-asserted-by":"crossref","unstructured":"Milburn JL Jr, Hirose H, Lee YH, Nagasawa Y, Ogawa A, Ohneda M, BeltrandelRio H, Newgard CB, Johnson JH, Unger RH: Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem\u2008270:1295\u20131299,1995","DOI":"10.1074\/jbc.270.3.1295"},{"key":"2022031217240693700_R33","doi-asserted-by":"crossref","unstructured":"Mulder H, Martensson H, Sundler F, Ahren B: Differential changes in islet amyloid polypeptide (amylin): and insulin mRNA expression after high-fat diet-induced insulin resistance in C57BL\/6J mice: Metabolism\u200849:1518\u20131522,2000","DOI":"10.1053\/meta.2000.18511"},{"key":"2022031217240693700_R34","unstructured":"Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJS, Holman RR, Turner RC: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type-2 diabetes. Diabetes Res Clin Exp\u20089:151\u2013159,1988"},{"key":"2022031217240693700_R35","doi-asserted-by":"crossref","unstructured":"Kahn SE, Andrikopoulos S, Verchere CB: Islet amyloid: A long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes\u200848:241\u2013253,1999","DOI":"10.2337\/diabetes.48.2.241"},{"key":"2022031217240693700_R36","doi-asserted-by":"crossref","unstructured":"Kahn SE: The importance of \u03b2-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab\u200886:4047\u20134058,2001","DOI":"10.1210\/jcem.86.9.7713"},{"key":"2022031217240693700_R37","doi-asserted-by":"crossref","unstructured":"Ahren B: Reducing plasma free fatty acids by acipimox improves glucose tolerance in high-fat fed mice. Acta Physiol Scand\u2008171:161\u2013167,2001","DOI":"10.1046\/j.1365-201x.2001.00794.x"},{"key":"2022031217240693700_R38","doi-asserted-by":"crossref","unstructured":"Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B: Heterogeneous metabolic adaptation of C57BL\/6J mice to high-fat diet. Am J Physiol Endocrinol Metab\u2008282:E834\u2013E842,2002","DOI":"10.1152\/ajpendo.00332.2001"},{"key":"2022031217240693700_R39","doi-asserted-by":"crossref","unstructured":"Black BL, Croom J, Eisen EJ, Petro AE, Edwards CL, Surwit RS: Differential effects of fat and sucrose on body composition in A\/J and C57BL\/6 mice. Metabolism\u200847:1354\u20131359,1998","DOI":"10.1016\/S0026-0495(98)90304-3"},{"key":"2022031217240693700_R40","doi-asserted-by":"crossref","unstructured":"Schreyer SA, Wilson DL, LeBoeuf RC: C57BL\/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis. Atherosclerosis\u2008136:17\u201324,1998","DOI":"10.1016\/S0021-9150(97)00165-2"},{"key":"2022031217240693700_R41","doi-asserted-by":"crossref","unstructured":"Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M: Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL\/6J and A\/J mice. Metabolism\u200844:645\u2013651,1995","DOI":"10.1016\/0026-0495(95)90123-X"},{"key":"2022031217240693700_R42","doi-asserted-by":"crossref","unstructured":"Pacini G, Thomaseth K, Ahren B: Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab\u2008281:E693\u2013E703,2001","DOI":"10.1152\/ajpendo.2001.281.4.E693"},{"key":"2022031217240693700_R43","doi-asserted-by":"crossref","unstructured":"Gedulin B, Cooper GJS, Young AA: Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats. Biochem Biophys Res Comm\u2008180:782\u2013789,1991","DOI":"10.1016\/S0006-291X(05)81133-7"},{"key":"2022031217240693700_R44","doi-asserted-by":"crossref","unstructured":"Brethertonwatt D, Ghatei MA, Bloom SR, Jamal H, Ferrier GJM, Girgis SI, Legon S: Altered islet amyloid polypeptide (amylin) gene-expression in rat models of diabetes. Diabetologia\u200832:881\u2013883,1989","DOI":"10.1007\/BF00297454"},{"key":"2022031217240693700_R45","doi-asserted-by":"crossref","unstructured":"O\u2019Brien TD, Westermark P, Johnson KH: Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats. Diabetes\u200840:1701\u20131706,1991","DOI":"10.2337\/diabetes.40.12.1701"},{"key":"2022031217240693700_R46","doi-asserted-by":"crossref","unstructured":"Ludvik B, Clodi M, Kautzkywiller A, Capek M, Hartter E, Pacini G, Prager R: Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin-secretion in humans. Diabetologia\u200836:84\u201387,1993","DOI":"10.1007\/BF00399099"},{"key":"2022031217240693700_R47","doi-asserted-by":"crossref","unstructured":"Bjorklund A, Grill V: Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets. Diabetes\u200848:1409\u20131414,1999","DOI":"10.2337\/diabetes.48.7.1409"},{"key":"2022031217240693700_R48","doi-asserted-by":"crossref","unstructured":"Porte D Jr, Kahn SE: Hyperproinsulinemia and amyloid in NIDDM: Clues to etiology of islet \u03b2-cell dysfunction?Diabetes\u200838:1333\u20131336,1989","DOI":"10.2337\/diabetes.38.11.1333"},{"key":"2022031217240693700_R49","doi-asserted-by":"crossref","unstructured":"Zhou YP, Grill VE: Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. J Clin Invest\u200893:870\u2013876,1994","DOI":"10.1172\/JCI117042"},{"key":"2022031217240693700_R50","doi-asserted-by":"crossref","unstructured":"Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ: Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest\u2008101:1094\u20131101,1998","DOI":"10.1172\/JCI420"},{"key":"2022031217240693700_R51","doi-asserted-by":"crossref","unstructured":"Furukawa H, Carroll RJ, Swift HH, Steiner DF: Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic \u03b2-cell line MIN6. Diabetes\u200848:1395\u20131401,1999","DOI":"10.2337\/diabetes.48.7.1395"},{"key":"2022031217240693700_R52","doi-asserted-by":"crossref","unstructured":"Badman MK, Shennan KIJ, Jermany JL, Docherty K, Clark A: Processing of pro-islet amyloid polypeptide (proIAPP) by the prohormone convertase PC2. FEBS Lett\u2008378:227\u2013231,1996","DOI":"10.1016\/0014-5793(95)01460-8"},{"key":"2022031217240693700_R53","doi-asserted-by":"crossref","unstructured":"Higham CE, Hull RL, Lawrie L, Shennan KI, Morris JF, Birch NP, Docherty K, Clark A: Processing of synthetic pro-islet amyloid polypeptide (proIAPP) \u2018amylin\u2019 by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro. Eur J Biochem\u2008267:4998\u20135004,2000","DOI":"10.1046\/j.1432-1327.2000.01548.x"},{"key":"2022031217240693700_R54","doi-asserted-by":"crossref","unstructured":"Wang J, Xu J, Finnerty J, Furuta M, Steiner DF, Verchere CB: The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site. Diabetes\u200850:534\u2013539,2001","DOI":"10.2337\/diabetes.50.3.534"},{"key":"2022031217240693700_R55","doi-asserted-by":"crossref","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes\u200848:491\u2013498,1999","DOI":"10.2337\/diabetes.48.3.491"},{"key":"2022031217240693700_R56","doi-asserted-by":"crossref","unstructured":"Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus. Nature\u2008368:756\u2013760,1994","DOI":"10.1038\/368756a0"},{"key":"2022031217240693700_R57","doi-asserted-by":"crossref","unstructured":"Zhang S, Liu J, Saafi EL, Cooper GJ: Induction of apoptosis by human amylin in RINm5F islet beta-cells is associated with enhanced expression of p53 and p21WAF1\/CIP1. FEBS Lett\u2008455:315\u2013320,1999","DOI":"10.1016\/S0014-5793(99)00894-7"},{"key":"2022031217240693700_R58","doi-asserted-by":"crossref","unstructured":"Anguiano M, Nowak RJ, Lansbury PTJ: Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. Biochemistry\u200841:11338\u201311343,2002","DOI":"10.1021\/bi020314u"},{"key":"2022031217240693700_R59","doi-asserted-by":"crossref","unstructured":"Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP: The continuing epidemics of obesity and diabetes in the United States. JAMA\u2008286:1195\u20131200,2001","DOI":"10.1001\/jama.286.10.1195"},{"key":"2022031217240693700_R60","doi-asserted-by":"crossref","unstructured":"Bray GA, Popkin BM: Dietary fat intake does affect obesity! Am J Clin Nutr\u200868:1157\u20131173,1998","DOI":"10.1093\/ajcn\/68.6.1157"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/52\/2\/372\/660261\/db0203000372.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/52\/2\/372\/660261\/db0203000372.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:16:50Z","timestamp":1667405810000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/52\/2\/372\/26725\/Increased-Dietary-Fat-Promotes-Islet-Amyloid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2,1]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.52.2.372","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,2,1]]}}}